Clinical and Molecular Findings in Patients With Cervical/Supraclavicular Metastasis From Non-small-cell Lung Cancer (NSCLC)

CompletedOBSERVATIONAL
Enrollment

348

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

November 30, 2023

Conditions
Lung Cancer Metastatic
Interventions
PROCEDURE

Needle or forceps biopsy of cervical and/or supraclavicular lymph nodes

Patients with evidence of enlarged and/or PET positive cervical and/or supraclavicular lymph nodes suspected of being metastasis from lung cancer will be submitted to the biopsy from this location.

PROCEDURE

Needle, forceps or surgical biopsy of any lesion other than cervical and/or supraclavicular lymph nodes

Patients without evidence of enlarged and/or PET positive cervical and/or supraclavicular lymph nodes will be submitted to the biopsy considered less invasive and effective based on imaging data and clinical health status.

Trial Locations (1)

Unknown

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER